Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study

Christopher Alba, Shelly Malhotra, Stephanie Horsfall, Matthew E. Barnhart, Adrie Bekker, Katerina Chapman, Coleen K. Cunningham, Patricia E. Fast, Genevieve G. Fouda, Kenneth A. Freedberg, Ameena Goga, Lusine R. Ghazaryan, Valériane Leroy, Carlyn Mann, Margaret M. McCluskey, Elizabeth J. McFarland, Vincent Muturi-Kioi, Sallie R. Permar, Roger Shapiro, Devin Sok, Lynda Stranix-Chibanda, Milton C. Weinstein, Andrea L. Ciaranello, Caitlin M. Dugdale
doi: https://doi.org/10.1101/2023.11.06.23298184

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted November 07, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study
Christopher Alba, Shelly Malhotra, Stephanie Horsfall, Matthew E. Barnhart, Adrie Bekker, Katerina Chapman, Coleen K. Cunningham, Patricia E. Fast, Genevieve G. Fouda, Kenneth A. Freedberg, Ameena Goga, Lusine R. Ghazaryan, Valériane Leroy, Carlyn Mann, Margaret M. McCluskey, Elizabeth J. McFarland, Vincent Muturi-Kioi, Sallie R. Permar, Roger Shapiro, Devin Sok, Lynda Stranix-Chibanda, Milton C. Weinstein, Andrea L. Ciaranello, Caitlin M. Dugdale
medRxiv 2023.11.06.23298184; doi: https://doi.org/10.1101/2023.11.06.23298184
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area